Brief: Aeterna Zentaris Provides Business Update

COSCIENS Biopharma

17/01/2023 13:53

Jan 17 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS PROVIDES BUSINESS UPDATE AND OUTLINES KEY
UPCOMING MILESTONES
    * AETERNA ZENTARIS INC - WILL NOT PURSUE FURTHER DEVELOPMENT
OF
VACCINE PLATFORM FOR EITHER COVID-19 OR CHLAMYDIA
    * AETERNA ZENTARIS INC - CO HAS ELECTED TO TERMINATE ITS
EXISTING
LICENSE AGREEMENTS WITH UNIVERSITY OF WUERZBURG FOR THAT VACCINE
PLATFORM TECHNOLOGY
    * AETERNA ZENTARIS INC - EXPECTS TO ACHIEVE APPROVALS TO
CONDUCT
DETECT TRIAL IN NEW COUNTRIES IN FIRST HALF OF 2023
    * AETERNA ZENTARIS INC- DECISION TO DISCONTINUE VACCINE
DEVELOPMENT, PROVIDES CO WITH ABILITY TO MEET ITS CURRENTLY
ANTICIPATED CASH NEEDS INTO 2025
    * AETERNA ZENTARIS INC - EXPECTS TO COMPLETE DETECT
ENROLLMENT BY
END OF 2023
    * AETERNA ZENTARIS INC - STRATEGIC DECISION TO STREAMLINE
PIPELINE
PROVIDES CO WITH ABILITY TO MEET ITS CURRENTLY ANTICIPATED CASH
NEEDS INTO 2025

Source text for Eikon:  ID:nGNX5GzPx2 
Further company coverage:  AEZS.TO